ARTICLE | Clinical News
Qnasl beclomethasone dipropionate nasal aerosol regulatory update
June 2, 2014 7:00 AM UTC
Teva said FDA accepted for review an sNDA for Qnasl beclomethasone dipropionate nasal aerosol to treat seasonal and perennial allergic rhinitis in children 4-11 years of age. The nasal aerosol non-aqu...